West Nile virus infection induces depletion of IFNAR1 protein levels

Viral Immunology

Volumn 24, Issue 4, 2011, Pages 253-263

  Evans, Jared D ^a,b,c   Crown, Rachel A ^b   Sohn, Ji A ^a   Seeger, Christoph ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON RECEPTOR; INTERFERON ALPHA RECEPTOR SUBUNIT 1; INTERLEUKIN 12 RECEPTOR BETA1; PROTEASOME; SERINE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CELL TYPE; CONTROLLED STUDY; FLAVIVIRUS INFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; LYSOSOME; NONHUMAN; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UNFOLDED PROTEIN RESPONSE; WEST NILE FLAVIVIRUS; WEST NILE VIRUS INFECTION;

ANIMALS; CELL LINE; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; RECEPTOR, INTERFERON ALPHA-BETA; WEST NILE VIRUS;

WEST NILE VIRUS;

EID: 80051732976     PISSN: 08828245     EISSN: 15578976     Source Type: Journal    
DOI: 10.1089/vim.2010.0126     Document Type: Article

References (63)

1. Ashour J, Laurent-Rolle M, Shi OY, and Garcia-Sastre A: NS5 of dengue virus mediates STAT2 binding and degradation. J Virol 2009;83:5408-5418.
2. Bacon C, McVicar DW, Ortaldo JR, Rees RC, O'Shea JJ, and Johnston JA: Interleukin 12 (IL-12) induces tyrosine phosphorylation of JAK2 and Tyk2: differential use of Janus family tyrosine kinases by IL-2 and IL-12. J Exp Med 1995;181:399-404.
3. Bailly F, Si N, Si A, and Trepo C: Treatment of HCV liver disease by recombinant interferon alpha. Nephrol Dial Transplant 1996;11(Suppl 4):56-57. (Pubitemid 26345109)
4. Best SM, Morris KL, Shannon JG, et al.: Inhibition of interferon- stimulated JAK-STAT signaling by a tick-borne flavivirus and identification of NS5 as an interferon antagonist. J Virol 2005;79:12828-12839. (Pubitemid 41433202)
5. Brinton MA: The molecular biology of West Nile Virus: a new invader of the Western hemisphere. Annu Rev Microbiol 2002;56:371-402. (Pubitemid 35217460)
6. Byrne S, Halliday GM, Johnston LJ, and King NJ: Interleukin-1 beta but not tumor necrosis factor is involved in West Nile virus-induced Langerhans cell migration from the skin in C57BL/6 mice. J Invest Dermatol 2001;117:702-709. (Pubitemid 32955601)
7. Chee AV, and Roizman B: Herpes simplex virus 1 gene products occlude the interferon signaling pathway at multiple sites. J Virol 2004;78:4185-4196. (Pubitemid 38437224)
8. Colamonici O, Yan H, Domanski P, et al.: Direct binding to and tyrosine phosphorylation of the alpha subunit of the type I interferon receptor by p135tyk2 tyrosine kinase. Mo Cell Biol 1994;14:8133-8142.
9. Colamonici OR, Uyttendaele H, Domanski P, Yan H, and Krolewski JJ: p135tyk2, an interferon-alpha-activated tyrosine kinase, is physically associated with an interferon-alpha receptor. J Biol Chem 1994;269:3518-3522.
10. Constantinescu SN, Croze E, Murti A, et al.: Expression and signaling specificity of the IFNAR chain of the type I interferon receptor complex. Proc Natl Acad Sci USA 1995; 92:10487-10491.
11. Domanski P, Fish E, Nadeau OW, Witte M, Platanias LC, Yan H, Krolewski J, Pitha P, and Colamonici OR: A region of the beta subunit of the interferon alpha receptor different from box 1 interacts with Jak1 and is sufficient to activate the Jak-Stat pathway and induce an antiviral state. J Biol Chem 1997;272:26388-26393. (Pubitemid 27458855)
12. Emeny JM, and Morgan MJ: Regulation of the interferon system: evidence that Vero cells have a genetic defect in interferon production. J Gen Virol 1979;43:247-252. (Pubitemid 9181666)
13. Evans JD, and Seeger C: Differential effects of mutations in NS4B on West Nile virus replication and inhibition of interferon signaling. J Virol 2007;81:11809-11816. (Pubitemid 47623813)
14. Festi D, Sandri L, Mazzella G, et al.: Safety of interferon beta treatment for chronic HCV hepatitis. World J Gastroenterol 2004;10:12-16. (Pubitemid 38071969)
15. Fredericksen BL, and Gale M Jr: West Nile virus evades activation of interferon regulatory factor 3 through RIG-Idependent and -independent pathways without antagonizing host defense signaling. J Virol 2006;80:2913-2923. (Pubitemid 43346386)
16. Gauzzi MC, Velazquez L, McKendry R, Mogensen KE, Fellous M, and Pellegrini S: Interferon-alpha-dependent activation of Tyk2 requires phosphorylation of positive regulatory tyrosines by another kinase. J Biol Chem 1996; 271:20494-20500. (Pubitemid 26281822)
17. Granwehr BP, Lillibridge KM, Higgs S, Mason PW, Aronson JF, Campbell GA, and Barrett AD: West Nile virus: where are we now? Lancet Infect Dis 2004;4:547-556. (Pubitemid 39141795)
18. Gubler DJ: The continuing spread of West Nile virus in the Western hemisphere. Clin Infect Dis 2007;45:1039-1046. (Pubitemid 47580356)
19. Guo JT, Hayashi J, and Seeger C: West Nile virus inhibits the signal transduction pathway of alpha interferon. J Virol 2005;79:1343-1350. (Pubitemid 40459081)
20. Hayes EB, Sejvar JJ, Zaki SR, Lanciotti RS, Bode AV, and Campbell GL: Virology, pathology, and clinical manifestations of West Nile virus disease. Emerg Infect Dis 2005; 11:1174-1179. (Pubitemid 41045322)
21. Horvath CM: Weapons of STAT destruction. Interferon evasion by paramyxovirus V protein. Eur J Biochem 2004;271:4621-4628. (Pubitemid 40065565)
22. Jiang D, Weidner JM, Qing M, et al.: Identification of five interferon-induced cellular proteins that inhibit West Nile virus and dengue virus infections. J Virol 2010;84:8332-8341.
23. Kaleem A, Ahmad I, Hoessli DC, Walker-Nasir E, Saleem M, Shakoori AR, and Nasir Ud D: Epidermal growth factor receptors: function modulation by phosphorylation and glycosylation interplay. Mol Biol Rep 2009;36:631-639.
24. Kim R, Emi M, Tanabe K, and Murakami S: Role of the unfolded protein response in cell death. Apoptosis 2006p; 11:5-13. (Pubitemid 43151639)
25. Kumar K, Varhese B, Banerjee A, Baker DP, Constantinescu SN, Pellegrini S, and Fuchs SY: Basal ubiquitin-independent internalization of interferon alpha receptor is prevented by Tyk2-mediated masking of a linear endocytic motif. J Biol Chem 2008;283:18566-18572.
26. Kumar K, Barriere H, Carbone CJ, et al.: Site-specific ubiquitination exposes a linear motif to promote interferon- alpha receptor endocytosis. J Cell Biol 2007;179:935-950. (Pubitemid 350223490)
27. Kumar K, Krolewski JJ, Fuchs SY: Phosphorylation and specific ubiquitin acceptor sites are required for ubiquitination of the IFNAR1 subunit of type I interferon receptor. J Biol Chem 2004;279:46614-46620. (Pubitemid 39518306)
28. Kumar K, Tang W, Ravindranath AK, Clark WA, Croze E, and Fuchs SY: SCF(HOS) ubiquitin ligase mediates the ligand- induced down-regulation of the interferon-alpha receptor. EMBO J 2003;22:5480-5490. (Pubitemid 37279957)
29. Laurent-Rolle M, Boer EF, Lubick KJ, et al.: The NS5 protein of the virulent West Nile virus NY99 strain is a potent antagonist of type I interferon-mediated JAK-STAT signaling. J Virol 2010;84:3503-3515.
30. Li X, Leung S, Kerr IM, and Stark GR: Functional subdomains of STAT2 required for preassociation with the alpha interferon receptor and for signaling. Mol Cell Biol 1997;17:2048-2056. (Pubitemid 27133290)
31. Lin RJ, Chang BL, Yu HP, Liao CL, and Lin YL: Blocking of interferon-induced Jak-Stat signaling by Japanese encephalitis virus NS5 through a protein tyrosine phosphatasemediated mechanism. J Virol 2006;80:5908-5918.
32. Lin RJ, Liao CL, Lin E, and Lin YL:. Blocking of the alpha interferon-induced Jak-Stat signaling pathway by Japanese encephalitis virus infection. J Virol 2004;78:9285-9294. (Pubitemid 39096538)
33. Lindenbach BD, and Rice CM: Molecular biology of flaviviruses. Adv Virus Res 2003;59:23-61. (Pubitemid 137639363)
34. Lindenbach BD, and Rice CM: Flaviviridae: the viruses and their replication. In: Fields Virology, 4th ed. (Knipe HP, ed.). Lippincott, Williams, & Wilkins, Philadelphia, pp. 991-1041, 2001.
35. Ling LE, Zafari M, Reardon D, Brickelmeier M, Goelz SE, and Benjamin CD: Human type I interferon receptor, IFNAR, is a heavily glycosylated 120-130 kD membrane protein. J Interferon Cytokine Res 1995;15:55-61.
36. Liu J, HuangFu WC, Kumar KG, et al.: Virus-induced unfolded protein response attenuates antiviral defenses via phosphorylation-dependent degradation of the type I interferon receptor. Cell Host Microbe 2009;5:72-83.
37. Liu WJ, Chen HB, Wang XJ, Huang H, and Khromykh AA: Analysis of adaptive mutations in Kunjin virus replicon RNA reveals a novel role for the flavivirus nonstructural protein NS2A in inhibition of beta interferon promoter-driven transcription. J Virol 2004;78:12225-12235. (Pubitemid 39458742)
38. Liu WJ, Wang XJ, Mokhonov VV, Shi PY, Randall R, and Khromykh AA: Inhibition of interferon signaling by the New York 99 strain and Kunjin subtype of West Nile virus involves blockage of STAT1 and STAT2 activation by nonstructural proteins. J Virol 2005;79:1934-1942. (Pubitemid 40459140)
39. Marciniak SJ, Yun CY, Oyadomari S, et al.: CHOP induces death by promoting protein synthesis and oxidation in the stressed endoplasmic reticulum. Genes Dev 2004;18:3066-3077. (Pubitemid 39658175)
40. Marijanovic Z, Ragimbeau J, Kumar KG, Fuchs SY, and Pellegrini S: TYK2 activity promotes ligand-induced IFNAR1 proteolysis. Biochem J 2006;397:31-38. (Pubitemid 44032833)
41. Mazzon M, Jones M, Davidson A, Chain B, and Jacobs M: Dengue virus NS5 inhibits interferon-alpha signaling by blocking signal transducer and activator of transcription 2 phosphorylation. J Infect Dis 2009;200:1261-1270.
42. Medigeshi GR, Lancaster AM, Hirsch AJ, et al.: West Nile virus infection activates the unfolded protein response, leading to CHOP induction and apoptosis. J Virol 2007; 81:10849-10860. (Pubitemid 47536059)
43. Miller DM, Rahill BM, Boss JM, Lairmore MD, Durbin JE, Waldman JW, and Sedmak DD: Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway. J Exp Med 1998; 187:675-683. (Pubitemid 28115183)
44. Munoz-Jordan JL, Laurent-Rolle M, Ashour J, Martinez- Sobrido L, Ashok M, Lipkin WI, and Garcia-Sastre A: Inhibition of alpha/beta interferon signaling by the NS4B protein of flaviviruses. J Virol 2005;79:8004-8013. (Pubitemid 40853504)
45. Munoz-Jordan JL, Sanchez-Burgos GG, Laurent-Rolle M, and Garcia-Sastre A: Inhibition of interferon signaling by dengue virus. Proc Natl Acad Sci USA 2003;100:14333-14338. (Pubitemid 37499237)
46. Nisenbaum C, and Wallis K: Meningo-encephalitis due to West Nile fever. Reports of 2 cases. Helv Paediatr Acta 1965;20:392-402.
47. Oyadomari S, and Mori M: Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ 2004;11:381-389. (Pubitemid 38489416)
48. Park GS, Morris KL, Hallett RG, Bloom ME, and Best SM: Identification of residues critical for the interferon antagonist function of Langat virus NS5 reveals a role for the RNAdependent RNA polymerase domain. J Virol 2007;81:6936-6946. (Pubitemid 46986630)
49. Petersen LR, and Marfin AA: West Nile virus: a primer for the clinician. Ann Intern Med 2002;137:173-179. (Pubitemid 34827513)
50. Petersen LR, Roehrig JT, and Hughes JM: West Nile virus encephalitis. N Engl J Med 2002;347:1225-1226. (Pubitemid 35176240)
51. Ragimbeau J, Alcover EDA, Eid P, Uze G, and Pellegrini S: The tyrosine kinase Tyk2 controls IFNAR1 cell surface expression. EMBO J 2003;22:537-547. (Pubitemid 36193598)
52. Richter MF, Dumenil G, Uze G, Fellous M, and Pellegrini S: Specific contribution of Tyk2 JH regions to the binding and the expression of the interferon alpha/beta receptor component IFNAR1. J Biol Chem 1998;273: 24723-24729. (Pubitemid 28454973)
53. Sampson BA, Ambrosi C, Charlot A, Reiber K, Veress JF, and Armbrustmacher V: The pathology of human West Nile Virus infection. Hum Pathol 2000;31:527-531. (Pubitemid 30323977)
54. Sejvar JJ, Haddad MB, Tierney BC, et al.: Neurologic manifestations and outcome of West Nile virus infection. JAMA 2003;290:511-515. (Pubitemid 37430505)
55. Sejvar JJ, Leis AA, Stokic DS, et al.: Acute flaccid paralysis and West Nile virus infection. Emerg Infect Dis 2003;9:788-793. (Pubitemid 36801577)
56. Shi PY, Tilgner M, Lo MK, Kent KA, and Bernard KA: Infectious cDNA clone of the epidemic West Nile virus from New York City. J Virol 2002;76:5847-5856. (Pubitemid 34556279)
57. Su HL, Liao CL, and Lin YL: Japanese encephalitis virus infection initiates endoplasmic reticulum stress and an unfolded protein response. J Virol 2002;76:4162-4171.
58. Takaoka A, and Yanai H: Interferon signalling network in innate defence. Cell Microbiol 2006;8:907-922. (Pubitemid 43670834)
59. Waris G, Tardif KD, and Siddiqui A: Endoplasmic reticulum (ER) stress: hepatitis C virus induces an ERnucleus signal transduction pathway and activates NF-kappaB and STAT-3. Biochem Pharmacol 2002;64: 1425-1430. (Pubitemid 35333370)
60. Yamshchikov VF, Wengler G, Perelygin AA, Brinton MA, and Compans RW: An infectious clone of the West Nile flavivirus. Virology 2001;281:294-304. (Pubitemid 32881145)
61. Yokota S, Yokosawa N, Kubota T, et al.: Herpes simplex virus type 1 suppresses the interferon signaling pathway by inhibiting phosphorylation of STATs and janus kinasesduring an early infection stage. Virology 2001;286: 119-124. (Pubitemid 32675472)
62. Yu CY, Hsu YW, Liao CL, and Lin YL: Flavivirus infection activates the XBP1 pathway of the unfolded protein response to cope with endoplasmic reticulum stress. J Virol 2006;80:11868-11880.
63. Zou J, Presky DH, Wu CY, and Gubler U: Differential associations between the cytoplasmic regions of the interleukin-12 receptor subunits beta1 and beta2 and JAK kinases. J Biol Chem 1997;272:6073-6077. (Pubitemid 27102449)